Peter Libby, M.D. – Program co-chair
Mallinckrodt Professor of Medicine
Harvard Medical School

Jean-Claude Tardif, M.D. – Program co-chair
Director, Research Center
Montreal Heart Institute

Eric Abadie, M.D.
Director, Therapeutics Evaluation, AFSSAPS
European Medicines Agency (EMEA)

Robert S. Balaban, M.D., Ph.D.
National Heart, Lung and Blood
Institute
National Institutes of Health

Christie Ballantyne, M.D.
Director, Ctr. for Cardiovascular
Disease Prev.
Baylor College of Medicine

Philip Barter, M.D.
Professor of Medicine
University of Sydney

Russell Basser, M.D.
Global Director of Clinical
Development
CSL, Ltd.

Colin Berry, BSc., M.D., Ph.D.
Cardiovascular MRI / CV Intervention Program
NHLBI, National Institutes of Health

Donald M. Black, MBA, M.D.
Global Head of Research and Development
General Electric Healthcare

Eric P. Brass, M.D., Ph.D.
Professor of Medicine
Harbor-UCLA Medical Center

H. Bryan Brewer, Jr., M.D.
Director of Lipoprotein and Atherosclerosis Research
MedStar Research Institute

David G. Brown, Ph.D.
NIBIB/CDRH Laboratory for the Assessment of Medical Imaging Systems
US FDA

Gregory Campbell, Ph.D.
Director, Division of Biostatistics
US FDA, CDRH

Christopher Cannon, M.D.
Associate Prof. of Medicine,
Brigham and Women’s Hospital

Eric Colman, M.D.
Division of Metabolism and Endocrine
Center for Drug Evaluation and Research, US FDA

Carolyn C. Compton, M.D., Ph.D.
Director, Office of Biorepositories and Biospecimen Research (OBBR)
National Cancer Institute, National Institutes of Health

Hayes Dansky, M.D.
Director, Cardiovascular Disease
Merck Research Laboratories

Michael Davidson, M.D.
Director of Preventive Cardiology
University of Chicago School of Medicine

James De Lemos, M.D.
Associate Professor and CCU Director
University of Texas-Southwestern  Medical School

Benjamin Eloff, Ph.D.
Office of Scientific and Medical Programs
Office of the Commissioner, US FDA

Zahi A. Fayad, Ph.D.
Professor, Departments of Radiology and Med.
Mount Sinai School of Medicine

Brandon D. Gallas, Ph.D.
NIBIB/CDRH Laboratory for the Assessment of Medical Imaging Systems
US FDA

Felix W. Frueh, Ph.D.
Vice President, R&D Personalized Medicine
Medco Health Solutions, Inc.

Jean-Jacques Garaud, M.D.
Head of Global Drug Development
F. Hoffmann-La Roche Ltd

Federico Goodsaid, Ph.D.
Office of Clinical Pharmacology
Center for Drug Evaluation and Research, US FDA

Mark Grant, M.D.
Senior Scientist, Technology Evaluation Center
Blue Cross Blue Shield Association

Patricia P. Harlow, Ph.D.
Division of Cardiovascular and Renal Drug Products
US FDA, CDER

Jay Heinecke, M.D.
Professor of Medicine
University of Washington

Therese Heinonen, D.V.M.
Associate Director, Medical and Scien. Affairs
Montreal Heart Institute Coord. Center

Hylton Joffe, M.D.
Division of Metabolism and Endocrine
Center for Drug Evaluation and Research, US FDA

Dominique Johnson, Ph.D.
Director
Montreal Heart Institute Coord. Center

Agnes Klein, M.D.
Director, Ctr. for Eval. of Radiopharm. and Biotherapeutics, Health Canada

Wolfgang Koenig, M.D.
Professor of Medicine and Cardiology
University of Ulm Medical Center

Jeff Leiden, M.D., Ph. D.
Managing Director
Clarus Ventures

Lawrence Leiter, M.D.
Head, Endocrinology and Metabolism
St. Michael’s Hospital, Toronto

João A.C. Lima, M.D.
Assoc. Prof. of Med., Rad. and Epidemiology
Johns Hopkins University

Elizabeth Mansfield, Ph.D.
Senior Policy Analyst, Office of In Vitro Diag. Device Eval. and Safety, CDRH, USFDA

George A. Mensah, M.D.
National Ctr. for Chronic Dis. Prev. and Health Prom., Centers for Disease Control and Prevention

Michele Mercuri, M.D., Ph.D.
Head Pharma Scientific Review Committee
Novartis Pharmaceuticals Corp.

George Mills, M.D.
Vice President, Medical Imaging Consulting
Perceptive Informatics

Jacques Mizrahi, M.D.
Head, Metabolic Diseases
F. Hoffmann-LaRoche

Christopher O'Donnell, M.D.
Senior Advisor, Genome Research 
NHLBI, National Institutes of Health

David Orloff, M.D.
Executive Director, Reg Affairs
Medpace Inc.

Mary Parks, M.D.
Division of Metabolism and Endocrine
Center for Drug Evaluation and Research, US FDA

Michael Perelman, M.D.
Vice President, Global Project Mgmt
Schering-Plough Research Institute

Joel Raichlen, M.D.
Senior Director, Clinical Research
Astra-Zeneca

Gurvaneet Randhawa, M.D.
Center for Outcomes and Evidence
Agency for Healthcare Research and Quality

Paul M. Ridker, M.D.
Center for Cardiovascular Disease Prevention
Brigham and Women’s Hospital

Dwaine Rieves, M.D.
Director, Medical Imaging
Center for Drug Evaluation and Research, US FDA

John Rioux, Ph.D.
The Lab of Genetics and Genomic Med of Inflam., Montreal Heart Institute

Jean Rouleau, M.D.
Dean of Medicine
University of Montreal

Amy E. Rudolph, Ph.D.
Director, Glob. Med CV Metabolic Endocrine
Pfizer, Inc

Kerry-Anne Rye, Ph.D.
Head, Lipid Research Group
The Heart Research Institute, Sydney, AU

Philip Sager, M.D.
Chief Medical Officer
CardioDx, Inc.

Carl Sparrow, Ph.D.
Director, Lipid Biochemistry
Merck Research Laboratories

Norman Stockbridge, M.D.
Division of Cardio-Renal, Center for Drug Evaluation and Research, US FDA

Erik Stroes, M.D., Ph.D.
Department of Vascular Medicine
Academic Medical Center, Amsterdam

Anders Svensson, M.D.
Head of Clinical Development - Metabolism
F. Hoffman-LaRoche, Ltd.

Allen Taylor, M.D.
Chief, Cardiology Service
Walter Reed Army Medical Center

Robert Temple, M.D.
Director, Office of Medical Policy
US FDA

Douglas C. Throckmorton, M.D.
Deputy Center Director, Center for Drug Evaluation and Research, US FDA

Paula R. Trumbo, Ph.D.
Team Leader, Nutrition Science Eval. Center for Food Safety and App. Nutrition, US FDA

Roger Ulrich, Ph.D.
Cheif Development Officer
Calistoga Pharmaceuticals

David Waters, M.D.
Chief, Cardiovascular Medicine
University of California, San Francisco

Bram Zuckerman, M.D.
Director,
Center for Devices and Radiological Health, US FDA

ver. 06.25.08